Revenue
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.4M | $8.3M | $7.0M | $4.5M | $131,000 | $142,000 | $63,000 | — | — | — | — |
| Gross profit | $3.0M | $3.3M | $2.7M | $634,000 | $131,000 | $140,000 | $42,000 | — | — | — | — |
| Research & development | $597,000 | $429,000 | $974,000 | $1.7M | $4.2M | $1.5M | $1.5M | $1.1M | $845,000 | $727,000 | $301,000 |
| Operating expenses | $8.7M | $7.3M | $9.5M | $8.7M | $10.7M | $6.3M | $6.0M | $5.2M | $5.6M | $2.6M | $1.9M |
| Operating income | −$5.7M | −$3.9M | −$6.7M | −$8.1M | −$10.6M | −$6.1M | −$6.0M | −$5.2M | −$5.6M | −$2.6M | −$1.9M |
| EBITDAderived | −$5.4M | −$3.6M | −$6.4M | −$7.9M | — | — | — | — | — | — | — |
| Net income | −$5.9M | −$4.0M | −$6.4M | −$8.3M | −$10.5M | −$6.2M | −$5.5M | −$6.0M | −$5.4M | −$4.3M | −$3.4M |
| Basic EPSper diluted share | -$1.87 | -$4.39 | -$20.40 | -$7.47 | -$17.75 | -$1.11 | -$2.75 | -$3.03 | -$0.30 | -$0.27 | -$0.22 |
| Diluted EPSper diluted share | -$1.87 | -$4.39 | -$20.40 | -$7.47 | -$0.71 | -$1.11 | -$3.12 | -$3.03 | -$0.30 | -$0.27 | -$0.22 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 29, 2025Form 4 | Luzon RonenChief Executive Officer | BuyCommon Stock | 3.8K | $0.78 | $2.9K | 293.1K |
| Dec 1, 2025Form 4 | Luzon RonenChief Executive Officer | BuyCommon Stock | 2.6K | $0.91 | $2.4K | 74.3K |
| Nov 25, 2025Form 4 | Luzon RonenChief Executive Officer | BuyCommon Stock | 14.0K | $0.90 | $12.6K | 71.7K |
| Nov 24, 2025Form 4 | Luzon RonenChief Executive Officer | BuyCommon Stock | 235 | $0.89 | $209.15 | 57.7K |
| Nov 20, 2025Form 4 | Luzon RonenChief Executive Officer | BuyCommon Stock | 3.0K | $0.77 | $2.3K | 57.5K |